Treatment of lichen planopilaris with baricitinib: A retrospective study

Anthony Moussa; Bevin Bhoyrul; Leila Asfour; Ahmed Kazmi; Samantha Eisman; Rodney Daniel Sinclair

doi:10.1016/j.jaad.2022.02.027

Treatment of lichen planopilaris with baricitinib: A retrospective study

J Am Acad Dermatol. 2022 Sep;87(3):663-666. doi: 10.1016/j.jaad.2022.02.027. Epub 2022 Feb 22.

Authors

Anthony Moussa¹, Bevin Bhoyrul², Leila Asfour², Ahmed Kazmi², Samantha Eisman², Rodney Daniel Sinclair³

Affiliations

¹ Sinclair Dermatology, East Melbourne, Victoria, Australia. Electronic address: anthonymoussa@outlook.com.
² Sinclair Dermatology, East Melbourne, Victoria, Australia.
³ Sinclair Dermatology, East Melbourne, Victoria, Australia; University of Melbourne, Melbourne, Victoria, Australia.

PMID: 35202778
DOI: 10.1016/j.jaad.2022.02.027

No abstract available

Keywords: Janus kinase inhibitor; Lichen Planopilaris Activity Index; baricitinib; frontal fibrosing alopecia; hair follicle; immune privilege; interferon gamma; lichen planopilaris; lichen planus; signal transducer and activator of transcription; therapy; tofacitinib.

MeSH terms

Alopecia / drug therapy
Azetidines* / therapeutic use
Humans
Lichen Planus* / drug therapy
Purines
Pyrazoles
Retrospective Studies
Sulfonamides

Substances

Azetidines
Purines
Pyrazoles
Sulfonamides
baricitinib

Supplementary concepts

Lichen planus follicularis